Breast cancer care continues to evolve rapidly as new research helps clinicians personalize treatment and improve patient outcomes. In this episode of MedInsights Unleashed, Dr. Christine Simmons MD, Associate Professor in the Faculty of Medicine at the University of British Columbia (UBC) and specialist in breast cancer and sarcoma, reviews the most important breast cancer studies presented at ASCO 2026 and explains their implications for clinical practice.

The discussion explores advances in genomic testing, immunotherapy, GLP-1 agonists, antibody-drug conjugates, and circulating tumor DNA, highlighting how precision medicine is transforming breast cancer care.